The Type and Impact of Evidence Review Group Exploratory Analyses in the NICE Single Technology Appraisal Process
Research output: Contribution to journal › Article › peer-review
Standard Standard
In: Value in Health, Vol. 20, No. 6, 06.2017, p. 785-791.
Research output: Contribution to journal › Article › peer-review
HarvardHarvard
APA
CBE
MLA
VancouverVancouver
Author
RIS
TY - JOUR
T1 - The Type and Impact of Evidence Review Group Exploratory Analyses in the NICE Single Technology Appraisal Process
AU - Carroll, Christopher
AU - Kaltenthaler, Eva
AU - Hill-McManus, Daniel
AU - Scope, Alison
AU - Holmes, Michael
AU - Rice, Stephen
AU - Rose, Micah
AU - Tappenden, Paul
AU - Woolacott, Nerys
PY - 2017/6
Y1 - 2017/6
N2 - Background As part of the UK National Institute for Health and Care Excellence (NICE) single technology appraisal process, independent evidence review groups (ERGs) critically appraise a company's submission relating to a specific technology and indication. Objectives To explore the type of additional exploratory analyses conducted by ERGs and their impact on the recommendations made by NICE. Methods The 100 most recently completed single technology appraisals with published guidance were selected for inclusion. A content analysis of relevant documents was undertaken to identify and extract relevant data, and narrative synthesis was used to rationalize and present these data. Results The types of exploratory analysis conducted in relation to companies’ models were fixing errors, addressing violations, addressing matters of judgment, and the provision of a new, ERG-preferred base case. Ninety-three of the 100 ERG reports contained at least one of these analyses. The most frequently reported type of analysis in these 93 ERG reports related to the category “Matters of judgment,” which was reported in 83 reports (89%). At least one of the exploratory analyses conducted and reported by an ERG is mentioned in 97% of NICE appraisal consultation documents and 94% of NICE final appraisal determinations, and had a clear influence on recommendations in 72% of appraisal consultation documents and 47% of final appraisal determinations. Conclusions These results suggest that the additional analyses undertaken by ERGs in the appraisal of company submissions are highly influential in the policy-making and decision-making process.
AB - Background As part of the UK National Institute for Health and Care Excellence (NICE) single technology appraisal process, independent evidence review groups (ERGs) critically appraise a company's submission relating to a specific technology and indication. Objectives To explore the type of additional exploratory analyses conducted by ERGs and their impact on the recommendations made by NICE. Methods The 100 most recently completed single technology appraisals with published guidance were selected for inclusion. A content analysis of relevant documents was undertaken to identify and extract relevant data, and narrative synthesis was used to rationalize and present these data. Results The types of exploratory analysis conducted in relation to companies’ models were fixing errors, addressing violations, addressing matters of judgment, and the provision of a new, ERG-preferred base case. Ninety-three of the 100 ERG reports contained at least one of these analyses. The most frequently reported type of analysis in these 93 ERG reports related to the category “Matters of judgment,” which was reported in 83 reports (89%). At least one of the exploratory analyses conducted and reported by an ERG is mentioned in 97% of NICE appraisal consultation documents and 94% of NICE final appraisal determinations, and had a clear influence on recommendations in 72% of appraisal consultation documents and 47% of final appraisal determinations. Conclusions These results suggest that the additional analyses undertaken by ERGs in the appraisal of company submissions are highly influential in the policy-making and decision-making process.
KW - National Institute for Health and Care Excellence
KW - evidence review groups (ERGs)
KW - health policy
KW - single technology appraisal (STA)
U2 - 10.1016/j.jval.2016.08.729
DO - 10.1016/j.jval.2016.08.729
M3 - Article
VL - 20
SP - 785
EP - 791
JO - Value in Health
JF - Value in Health
SN - 1098-3015
IS - 6
ER -